Task: Answer the multiple-choice question.
Query: Which drug exhibits a -71.443% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) O=C1NC[C@H](c2ccccc2)N(CCC23CC4CC(CC(C4)C2)C3)C1=O
b) N#Cc1ccc(OCC(=O)N2CCN(S(=O)(=O)c3cccc(Cl)c3)CC2)cc1
Answer: b. N#Cc1ccc(OCC(=O)N2CCN(S(=O)(=O)c3cccc(Cl)c3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1ccc(OCC(=O)N2CCN(S(=O)(=O)c3cccc(Cl)c3)CC2)cc1
N#Cc1ccc(OCC(=O)N2CCN(S(=O)(=O)c3cccc(Cl)c3)CC2)cc1
4-[2-[4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-2-oxoethoxy]benzonitrile